ANTIBODY RESPONSE TO TRYPANOSOMA EVANSI IN CAMELS OF KAZAKHSTAN

Surra, caused by Trypanosoma evansi, is a major constraint to camel health and productivity in arid and semi-arid regions. Despite Kazakhstan’s large camel population, peer-reviewed data on surra epidemiology remain scarce.

A cross-sectional seroepidemiological survey was conducted in two camel-breeding regions of Kazakhstan (Mangystau and Kyzylorda) during 2024 and 2025. Serum samples (n = 2,745 in 2024; n = 2,900 in 2025) were tested for anti-T. evansi antibodies using the complement fixation test (CFT) and the formol gel test (FGT). Seroprevalence was expressed with 95% confidence intervals (CI), and regional/temporal differences were assessed using Pearson’s chi-square test.

In Mangystau, CFT prevalence decreased from 5.0% (95% CI: 2.15–11.18) in 2024 to 0.78% (95% CI: 0.21–2.82) in 2025 (p = 0.0319), while FGT positivity declined from 65.0% to 5.88% (p < 0.001). Conversely, in Kyzylorda, CFT prevalence increased significantly from 4.0% (95% CI: 3.32–4.82) to 8.88% (95% CI: 7.87–10.01; p < 0.001), whereas FGT values rose slightly from 7.8% to 8.96% without statistical significance (p = 0.1504).

This study provides one of the first systematic multi-year assessments of T. evansi circulation in camels in Kazakhstan, revealing contrasting regional dynamics, with a sharp decline in Mangystau and a significant increase in Kyzylorda. These findings underscore the heterogeneous nature of surra epidemiology and highlight the need for continued surveillance and combined diagnostic approaches to inform control strategies. 

1. Aregawi, W. G., Agga, G. E., Abdi, R. D., & Buscher, P. (2019). Systematic review and metaanalysis on the global distribution, host range, and prevalence of Trypanosoma evansi. Parasites & Vectors, 12, 67. https://doi.org/10.1186/s13071-019-3311-4

2. Selim, A., Abdelhady, A., Almohammed, H. I., et al. (2022). Seroprevalence, risk factors, and hematobiochemical changes associated with Trypanosoma evansi infection in dromedary camels. Animals, 12(18), 2401. https://doi.org/10.3390/ani12182401

3. Evans, G. (1880). On a new blood parasite found in camels: Trypanosoma evansi. Veterinary Journal, 11, 187–188.

4. Sazmand, A., & Joachim, A. (2017). Parasitic diseases of camels in Iran (1931–2017): A literature review. Parasite, 24, 21. https://doi.org/10.1051/parasite/2017024

5. Anonymous. (1935). Dr. Griffith Evans’s hundredth birthday. Canadian Medical Association Journal, 33(4), 430–431.

6. Desquesnes, M., Bossard, G., Thévenon, S., Patrel, D., Ravel, S., Pavlovic, D., et al. (2009). Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France. Veterinary Parasitology, 162(3–4), 214–220. https://doi.org/10.1016/j.vetpar.2009.02.007

7. Hoare, C. A. (1972). The Trypanosomes of Mammals: A Zoological Monograph. Blackwell Scientific Publications, Oxford.

8. Desquesnes, M., Holzmuller, P., Lai, D. H., Dargantes, A., Lun, Z. R., & Jittaplapong, S. (2013). Trypanosoma evansi and surra: A review and perspectives on transmission, epidemiology and control. Parasitology, 140(6), 692–714. https://doi.org/10.1017/S0031182012002276

9. Joshi, P. P., Shegokar, V. R., Powar, R. M., et al. (2005). Human Trypanosoma evansi infection in India. New England Journal of Medicine, 352(13), 1305–1306. https://doi.org/10.1056/NEJMoa042324

10. World Organisation for Animal Health (WOAH). (2021). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter: Trypanosomosis (T. evansi). https://www.woah.org

11. Hébert, L., Froger, D., Madeline, A., Lecouturier, F., Lemans, C., Zientara, S., 2023. European inter-laboratory profi-ciency test for dourine antibody detection using the complement fixation test. Vet. Sci. 10, 592.